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Abstract Pimaricin-loaded poly(N-isopropylacrylamide)
nanohydrogels with and without acrylic acid, were evaluated
as food-spoilage inhibitors in a model system and a real food
product: grape juice. Pimaricin was proposed as a non-
allergenic alternative to sulphites for protecting juices against
recontamination. However, pimaricin may degrade under con-
ditions and treatments (heating, acidification, lighting) com-
monly applied in producing fresh juices. Nanohydrogel en-
capsulation may be a feasible procedure to avoid pimaricin
degradation, improving its antimicrobial activity. Pimaricin-
free nanohydrogels did not affect the growth of the indicator
yeast either in the food model system or in grape juice. Con-
versely, pimaricin-loaded nanohydrogels effectively inhibited
the growth of the indicator yeast. In some cases, the inhibition
was extended even further than using free pimaricin. For in-
stance, in the food model system, pimaricin-loaded
nanohydrogels with acrylic acid (NPPNIPA-20AA(5)) prevented
the yeast growth for more than 81 h while free pimaricin was
only effective for 12 h. Despite pimaricin-loaded
nanohydrogels without acrylic acid (NPPNIPA(5)) were able to
reduce maximum yeast growth, as in all treatments with
pimaricin, the extent of the inhibitory effect was not signifi-
cantly (p>0.05) different to that achieved with free pimaricin.
In grape juice, both free pimaricin and NPPNIPA-20AA(5) treat-
ment completely inhibited the growth of the indicator yeast
until the end of the bioassay. However, the latter provided
similar inhibition levels using a smaller amount of pimaricin
due to PNIPA-20AA(5) protection and its controlled release
from the nanohydrogel. Therefore, nanohydrogel encapsula-
tion may help to optimise antifungal treatments and decrease
the incidence of food allergies.
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Nomenclature
A and B Maximum growth of the indicator
microorganism (expressed as OD)
A0 Initial growth of the indicator
microorganism (expressed as OD).
AA Acrylic acid
C Samples without any treatment
D Dose of pimaricin (μg mL−1)
Fmin The minimal residual fraction of
pimaricin achievable in different
matrices during pimaricin
degradation study
Ft Fraction of pimaricin
IC50 Half maximal inhibitory concentration
(μg mL−1)
Isopar™M Isoparaffinic synthetic hydrocarbon
k The pimaricin degradation rate (h−1)
K Real maximum response
(maximum latency, h)
LCST Lower critical solution temperature
NIPA N-isopropylacrylamide
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NMBA N,N′-methylenebisacrylamide
NPNIPA-20AA(5) Antimicrobial treatment with
PNIPA-20AA(5) nanohydrogel
suspension without pimaricin
NPNIPA(5) Antimicrobial treatment with
PNIPA(5) nanohydrogel suspension
without pimaricin
NPPNIPA-20AA(5) Antimicrobial treatment with
PNIPA-20AA(5) nanohydrogel
suspension loaded with pimaricin
NPPNIPA(5) Antimicrobial treatment with
PNIPA(5) nanohydrogel suspension
loaded with pimaricin
OD Optical density
P Samples treated with a free
pimaricin solution
PNIPA-20AA(5) Poly(N-isopropylacrylamide)
nanohydrogel copolymerized with
a 20 % (w/w) of acrylic acid using
5 % (w/w) of cross-linking
PNIPA Poly(N-isopropylacrylamide)
PNIPA(5) Poly(N-isopropylacrylamide)
nanohydrogel with 5 % (w/w)
of cross-linking
PNIPA/AA Poly(N-isopropylacrylamide)
nanohydrogel with or without
copolymerized acrylic acid
RP-HPLC Reverse-phase high-performance
liquid chromatography
S.D. Standard diluent solution
Span™ 83 Sorbitan sesquiolate
vmax Maximum growth rate (h
−1)
YPD broth Yeast extract at 15 g L−1, peptone
at 20 g L−1 and glucose at 20 g L−1
dissolved in distilled water and
sterilised
λ Time of latency (h)
Introduction
The global food packaging industry has a good deal to con-
tribute not only in addressing food losses but also in ensuring
food safety, as well as enhancing global food trade, which is a
key to the economic development of varying economies. If
there is an industry sector that is equally, if not more, dynamic
than the food sector, it is none other than the packaging indus-
try. Food accounts for 50 % of the global consumer packaging
industry, valued at US$ 380 billion as of 2009. If the beverage
sector is to be added, that will even increase to 69 % (Manalili
et al. 2011). The continued quest for innovation in food and
beverage packaging is mostly driven by consumer needs and
demands influenced by changing global trends, such as in-
creased life expectancy, fewer organisations investing in food
production and distribution, and regionally abundant and di-
verse food supply (Brody et al. 2008). All this combined with
the interest of consumers for healthy eating and its active
lifestyles is the key to the success of the ready-to-eat food
products like fresh fruit juices. However, the stability of these
products is compromised due to contamination by moulds and
yeasts, which involve a serious preservation problem. Stan-
dard thermal treatments do not allow for maintaining the or-
ganoleptic characteristics of the product and chemical preser-
vatives, such as sulphites, which may cause allergy problems
(Vally and Misso 2012). Therefore, natural preservatives such
as pimaricin can be a valuable alternative.
Pimaricin (natamycin) is a polyene macrolide fungicide
produced by submerged aerobic fermentation of Streptomyces
natalensis and related species (Farid et al. 2000; Vanden
Bossche et al. 2003). It is widely used in food industry as a
preservative on the surface of cheese, fruits and other non-
sterile products, such as meat and sausages (Stark and Tan
2003). Pimaricin has several advantages as food preservative:
it is non-toxic; it has no influence on taste or appearance; it has
a favourable consumer perception because it is a natural in-
gredient (contrary to chemical preservatives); it is active in
low concentrations; and it has no antibacterial activity so the
natural ripening process in fermented products is not influ-
enced (Stark and Tan 2003). Nevertheless, some important
technological disadvantages that limit its food applications
are indicated: pimaricin has a low solubility that limits its
use to surface treatments applications, and the chemical sta-
bility in acidic conditions and under light radiation is low
(Koontz et al. 2003; Stark and Tan 2003). This explains
why, although the initial microbial load in a processed food
is usually low, food preservatives are directly added at a high
concentration when manufactured keeping an effective con-
centration during storage. However, preservative concentra-
tions could be reduced (and, consequently, its intake by con-
sumers) maintaining suitable levels of food safety by using the
delivery system as proposed by active packaging
technologies.
Traditional packaging protects food from external influ-
ences, such as microorganisms, oxygen, off-odours, light
etc. and, by doing so, guarantees convenience in food han-
dling and preserves the food quality for an extended time
period. The key safety objective for these traditional materials
in contact with foods is to be as inert as possible, i.e. there
should be a minimum interaction between food and packaging
(Dainelli et al. 2008). In recent years, however, one of the
most innovative developments in the area of food packaging
is active and smart packaging based on the interaction of
packages with food and environment and playing a dynamic
role in food preservation (Brody et al. 2008; Dainelli et al.
2008). Smart packaging responds to environmental conditions
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by improving food protection (e.g. by antimicrobial release) or
alerting consumers of contamination and/or the presence of
pathogens (Sekhon 2010). In active and smart packaging,
nanotechnology has a great potential because nanostructures
display a high surface-to-volume ratio and specific surface
properties. Recent studies also show that nanoparticles can
be tailored for both controlled release and/or specificity in
the action of the active agent, with moisture or temperature
as triggering mechanisms (Dainelli et al. 2008).
Nanohydrogels of poly(N-isopropylacrylamide) (PNIPA)
are cross-linked polymeric networks from 10 to 1000 nm
swollen by a good solvent. Since they are biocompatible and
non-toxic, they are commonly used as carriers or delivery
devices in anticancer applications and suitable for food use.
PNIPA nanohydrogels are thermosensitive with a lower criti-
cal solution temperature (LCST) of around 33 °C. Above the
LCST, hydrophobic interactions within polymer chains are
dramatically strengthened, leading to the abrupt collapse of
the polymer chains and the phase transition of the gel network
(Zhang et al. 2002). The nanohydrogel collapse pattern can be
easily modulated varying the polymer composition by intro-
ducing different functional groups and so the release behav-
iour can change, allowing for a precise controlled delivery of
the loaded active agent (Eeckman et al. 2004). Thus, copoly-
merization of acrylic acid (AA) into PNIPA nanohydrogels
results in nanohydrogels with more subtle temperature transi-
tion (Fuciños et al. 2014a, b). This behaviour helps pimaricin
release from inside the polymer matrix, since AA provides
more hydrated shrunken states that favour a sustained
pimaricin release (Fuciños et al. 2014b).
The ability of PNIPA nanohydrogels copolymerized with
AA to transport and release pimaricin as a response of environ-
mental triggers such as temperature and pH was demonstrated
(Fuciños et al. 2012, 2014b). Additionally, in the work of
Fuciños et al. (2012), it was demonstrated that pimaricin anti-
microbial activity in a solid food model system was potentiated
when it was loaded into the PNIPA-20AA(5) nanohydrogel,
due to the protective effect of nanohydrogel against external
conditions (pH, light) that harmed pimaricin. However, to the
best of our knowledge, there has been no work about the use of
smart active packaging based on PNIPA nanohydrogels to con-
trol the microbial spoilage in real food. Therefore, the main
objective of this work was to investigate the effectiveness of
these systems in controlling spoilage due tomicrobial growth in
a liquid food model system and in fresh grape juice.
Materials and Methods
Materials
Commercial pimaricin (50 % pure pimaricin, 50 % lactose)
was obtained from VGP Pharmachem (Barcelona, Spain).
Pure pimaricin (M=665.73 g mol−1) from Streptomyces
chattanoogensis (≥95%, high-performance liquid chromatog-
raphy (HPLC)) was supplied by Sigma-Aldrich (Munich, Ger-
many). Dialysis bags (SnakeSkin™ pleated dialysis tubing),
with a molar mass cut-off of 3500 g mol−1, were supplied by
Pierce (Rockford, IL, USA).
NIPA (99%) fromAcros Organics (Geel, Belgium), acrylic
acid (AA; stabilised with hydroquinone monomethyl ether)
for synthesis,N,N′-methylenebisacrylamide (NMBA) for syn-
thesis and sodium bisulfite (NaHSO3) for analysis were sup-
plied byMerck (Darmstadt, Germany); isoparaffinic synthetic
hydrocarbon (Isopar™ M, 98 %) was kindly supplied by
Quimidroga, S.A. (Barcelona, Spain); sorbitan sesquiolate
(Span™ 83, 98 %) and PEG-40 sorbitol hexaoleate (Atlas™
G-1086, 98 %) were kindly supplied by Croda Ibérica, S.A.
(Barcelona, Spain); and chloroform and diethyl ether were
from Panreac (Barcelona, Spain).
Saccharomyces cerevisiae strain was obtained from
Colección Española de Cultivos Tipo (CECT; Spain). The
D(+)-glucose anhydrous PA-ACS, bacteriological peptone
and yeast extract were all obtained from Panreac (Barcelona,
Spain). Acetic acid puriss. p.a. ACS reagent (≥99.8 %) and
methanol CHROMASOLV® for HPLC (≥99.9 %) were ob-
tained from Sigma-Aldrich (Munich, Germany). Commercial
white grape juice was used as received.
Pimaricin Detection by Reverse Phase High-Performance
Liquid Chromatography
Pimaricin quantification by reverse-phase high-performance
liquid chromatography (RP-HPLC) was performed following
a modified method from Roberts et al. (2011), using an
Agilent 1200 system equipped with a Variable Wavelength
Detector (Agilent Technologies, Palo Alto, CA, USA). Sepa-
ration was performed employing an ACE®C18 column (4.6×
150 mm, 5 μm) with the column oven kept at 30 °C. The flow
rate was 1.0 mL min−1, the injection volume was 20 μL and
the detection wavelength was 319 nm. Mobile phase A
consisted in MilliQ water/acetic acid (97:3, v/v) and mobile
phase B consisted in methanol/acetic acid (97:3, v/v). Mobile
phase Awas maintained at 90 % for the first 6 min, and then
decreased linearly to 10 % over 25 min. Finally, mobile phase
Awas increased to 90 % and the column was re-equilibrated
for a further 9 min.
The assay response was highly linear (Fig. 1) within the
concentration range 0.05 to 10 μg mL−1 of pure pimaricin
dissolved in a methanol/MilliQ water/acetic acid solution
(50:47:3, v/v/v; standard diluent solution (S.D.)).
The accuracy of pimaricin quantification by RP-HPLCwas
determined by adding, in duplicate, pure pimaricin to culture
broth and grape juice to obtain final concentrations of
5 μg mL−1. Figure 2 shows an HPLC chromatogram at
319 nm of S.D., culture broth and grape juice added with the
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same amount of pimaricin. The recovery was very high:
98.11 % for the culture broth and 97.32 % for the grape juice.
Therefore, it was possible to avoid pimaricin extraction from
the matrices evaluated in this work before its detection by
HPLC.
Pimaricin Stability in Different Matrices
Pimaricin degradation was evaluated in two different matri-
ces: culture broth and grape juice. The culture broth was YPD
(yeast extract, 15 g L−1; peptone, 20 g L−1; glucose, 20 g L−1).
Bothmatrices, YPD broth and grape juice, were added with an
aqueous solution of commercial pimaricin (4 μg mL−1) and
stored at 37 and 25 °C, respectively. The pimaricin concentra-
tion was monitored daily over 15 days by RP-HPLC.
Pimaricin degradation in grape juice was also evaluated
under pasteurisation conditions. For this purpose grape juice
was added with an aqueous solution of commercial pimaricin
(3 μg mL−1) and heated at 80 °C in a thermostatic bath. Ali-
quots were removed at different time intervals (as short as
possible to obtain a smooth shape curve) within 1 h, and the
pimaricin concentration was also determined by RP-HPLC.
All the experiments were carried out in duplicate.
In order to standardise the results, the fraction of pimaricin
at each sampling time was calculated as follows:
Ft ¼ 1− C0−CtC0 ð1Þ
where Ct and C0 are the pimaricin concentration (μg mL
−1) at
time t and at the initial time, respectively.
Pimaricin remaining fraction at each time (Ft), standardised
according to Eq. 1, were fitted with the following equation:
Ft ¼ F0−Fminð Þe−k⋅t þ Fmin ð2Þ
where F0 is the initial fraction of pimaricin, Ft is the remaining
fraction of pimaricin at time t, Fmin is the minimal residual
fraction of pimaricin achievable in the different matrices, k is
the pimaricin degradation rate (h−1), and t is the sampling time
(h). The pimaricin half-life (h) can be calculated as ln2k .
Antimicrobial Activity
Preparation of Pimaricin-Loaded Nanohydrogel
The synthesis method for PNIPA(5) and PNIPA-20AA(5) were
as reported in Fuciños et al. (2012). For pure PNIPA
nanohydrogels (PNIPA(5)), the ratio of NIPA based on the
monomers (mNIPA/mmonomer) was 1. For NIPA copolymerized
with AA (PNIPA-20AA(5)) nanohydrogels mNIPA/mmonomer
was 0.80 and mAA/mmonomer was 0.20. Atlas™ G-1086 and
Span™ 83 were used as surfactants dissolved in Isopar™
and NMBA was used as cross-linking agent at a ratio
mNMBA/mmonomer=0.05. Polymerisation initiator was
NaHSO3 at a ratio mNaHSO3/mmonomer=0.01 and chloro-
form and diethyl ether were used to selectively purify
synthesised nanoparticles.
The method to prepare pimaricin-loaded nanohydrogels
was as reported in Fuciños et al. (2012), with some modifica-
tions. During the inhibition studies, YPD broth-replaced dis-
tilled water avoid broth dilution of the growing broth with
water during the subsequent dialysis process. PNIPA/AA
nanohydrogel powder was dispersed in a sterile YPD broth
by agitation using a magnetic stirrer during 3 h at ambient
temperature to allow the nanoparticles to swell. Then, this
suspension was mixed with a pimaricin solution in sterile
YPD broth to obtain final concentrations of 12.5 mg of
nanohydrogel per milliliter and 0.4 mg of commercial
pimaricin powder per milliliter (21.93 μg mL−1 of solubilised
Fig. 1 Pimaricin standard curve prepared in a standard diluent solution
(S.D.) for quantification by RP-HPLC
Fig. 2 HPLC chromatogram at 319 nm of standard diluent solution
(S.D.), YPD broth and grape juice, all added with pure pimaricin
(5 μg mL−1)
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pure pimaricin). The mixture was stirred overnight at 25 °C
(below LCST) to guarantee pimaricin incorporation into the
nanohydrogel. Nanohydrogel samples without pimaricin and
free pimaricin samples were processed under the same condi-
tions as above.
For the inhibition studies employing grape juice only, PNIP
A-20AA(5) nanohydrogel was used. Samples of the
nanohydrogel loaded with pimaricin, the nanohydrogel with-
out pimaricin and free pimaricin were prepared as explained
above, except that YPD broth was replaced with white grape
juice. The pH of the grape juice employed at this point was
increased to 8 during the loading step to guarantee the correct
swelling of the nanohydrogel because PNIPA-20AA(5) col-
lapses at the pH of the grape juice (3.5), as was seen in Fuciños
et al. (2014a). The experiments were carried out in duplicate,
under sterile conditions.
Preparation of Indicator Microorganism Suspension
In order to force spoilage in both food model system and real
food, S. cerevisiae was chosen as indicator microorganism
because, between the most commonly known spoilage yeast,
S. cerevisiae presents widely studied a physiological, bio-
chemical and genetic responses (Ollé Resa et al. 2014).
The 12-h culture of the indicator microorganism (6×
107 CFU mL−1) was prepared, in duplicate, with a stock cul-
ture of S. cerevisiae previously grown in YPD broth during
two consecutive precultures of 12 h each, to ensure that most
of the yeast cells were viable. For the inhibition studies in
grape juice, a second 12-h culture was performed inoculating,
in duplicate, grape juice (pH 3.5) with a 12-h culture growth in
YPD broth in a first step.
Dose-Response Assessment of Pimaricin: IC50
Dose-response assay was performed in two different matrices:
YPD broth and grape juice. Both matrices were inoculated
with the indicator microorganism prepared as explained in
Sect. 2.4.2. Their final optical density (OD) at 600 nm was
adjusted to 0.010 (1 mm path length). The required volume of
pimaricin stock solution, prepared under sterile conditions,
was added to each matrix to obtain final pimaricin concentra-
tions ranging from 0 to 10μgmL−1. They were then incubated
at 37 °C for the culture broth and 25 °C for the grape juice,
under agitation at 120 rpm. At selected times, aliquots of 1 mL
were removed, in duplicate, to monitor the S. cerevisiae
growth spectophotometrically (Beckman Coulter Inc., Brea,
CA, USA) at 600 nm. The obtained OD values were fitted
with Eq. 5, and the time of latency (λ) obtained from this
equation was used as a response of S. cerevisiae growth to
increasing concentrations (doses) of pimaricin.
The half maximal inhibitory concentration (IC50; μg mL
−1)
of pimaricin in both matrices, YPD broth and grape juice, was
calculated by fitting the dose-response data to Weibull’s equa-
tion, reparameterised to make the IC50 explicit as proposed in
Murado et al. (2002):
λD ¼ K 1−e
−ln2 DIC50
 α !
ð3Þ
where λD is the latency (h) of the indicator microorganism
obtained as a response to the exposure to different doses of
pimaricin (D; μg mL−1). K is the real maximum response
(maximum latency, h) and α is a shape parameter related to
the maximum slope of the response.
Antimicrobial Activity of Pimaricin-Loaded PNIPA/AA
Nanohydrogels
The following antimicrobial devices, obtained as explained in
Section 2.4.1, were tested: PNIPA(5) nanohydrogel suspension
without pimaricin (NPNIPA(5)), PNIPA(5) nanohydrogel sus-
pension loaded with pimaricin (NPPNIPA(5)), PNIPA-20AA(5)
nanohydrogel suspension without pimaricin (NPNIPA-20AA(5)),
PNIPA-20AA(5) nanohydrogel suspension loaded with
pimaricin (NPPNIPA-20AA(5)), free pimaricin solution (P). Cul-
ture samples without any treatment (C) were processed simul-
taneously under the same conditions. Three milliliters from
each system were placed in a dialysis bag and dialyzed against
12 mL of the YPD broth or grape juice, inoculated with the
indicator microorganism prepared as explained in Sect. 2.4.2.
Their final OD at 600 nm were adjusted to 0.020 and 0.010
(1 mm path length) in the experiments with YPD broth and
grape juice, respectively. The incubation temperature was
37 °C for the bioassay in culture broth. The bioassay in grape
juice was kept at 8 °C for 6 h and then the temperature was
raised to 25 °C, until the end of the experiment. The experi-
ments were carried out in duplicate under sterile conditions.
To monitor the S. cerevisiae growth, 2-μL aliquots were
removed from the dialysate at selected times and their OD
measured at 600 nm using a Thermo Scientific NanoDrop
2000c (Wilmington, DE, USA). Low volume samples were
taken in order to be able to assume a constant dialysis volume,
because sterile conditions did not allow for sample
replacement.
Specific inhibition was calculated as follows:
%Inhibition ¼ OD0−OD
OD0
; Specific inhibition ¼ %Inhibition
Ct
ð4Þ
where, OD0 is the optical density of the samples in the treatments
without pimaricin (C and NPNIPA-20AA(5)) and OD is the optical
density of samples with pimaricin (P and NPPNIPA-20AA(5)).
Ct is the pimaricin concentration (μg mL
−1) at each sam-
pling time.
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Growth Modelling
The logistic equation is widely used to describe and predict
the microbial growth inhibition (Zwietering et al. 1990;
Bozkurt and Erkmen 2001; Wachenheim et al. 2003; Vázquez
et al. 2008; Vázquez and Murado 2008). Nevertheless, the
traditional formal description of the logistic equation presents
some drawbacks when it comes to performing statistical com-
parisons on treatments with microbial growth inhibitors. In
addition to maximum growth, another valuable parameter
for comparative studies is the lag period. However, this pa-
rameter is not explicit in the logistic equation. Therefore, to
describe parameters with such a relevant biological meaning,
the logistic equation should be reparameterised (Zwietering
et al. 1990; Vázquez et al. 2008):
ODt ¼ B
1þ e2þ4⋅vmax BB λB−tð Þ
ð5Þ
where B is the maximum growth of the microorganism
(expressed as OD), vmax B is the maximum growth rate
(h−1), and λB and t are the latency and the sampling time,
respectively, both expressed in hours. However, this equation
is only useful for fitting microbial growth data in a single
phase. Previous works have attempted to model two-phase
microbial growth (Guerra et al. 2010) by just summing two
simple logistic functions. Nevertheless, this approach fails to
provide an explicit parameter to describe the actual maximum
growth in the second phase, which does not coincide with the
asymptote of the second logistic. In this work, a new
reparameterised form of a bilogistic function is proposed:
ODt ¼ A
1þ A
A0
−1
 
e−
4⋅vmaxA ⋅t
A
þ B−A
1þ e2 BþAþ2⋅λB ⋅vmaxBð ÞB−A −4⋅vmaxB ⋅tB−A
ð6Þ
where the first part of the model is a reparameterised logistic
function, commonly used in the literature to fit microorganism
growth or inactivation (Dalgaard and Koutsoumanis 2001;
Wachenheim et al. 2003; Dai et al. 2010), allowing us to
predict the antifungal effect on the first growth phase. A0
and A are, respectively, the initial and maximum growth of
the indicator microorganism (expressed as OD) in the first
step. vmax A is the maximum growth rate (h
−1) for this phase
in the presence of the inhibitor, and t (h) is the sampling time.
The second part of the model corresponds to a logistic equa-
tion reparameterised to explicitly show the maximum growth
(B, expressed as OD) and the latency of the second phase (λB,
h) that in this case, refers to the regeneration time required for
the yeast to repair the membrane damage caused by pimaricin
(Te Welscher et al. 2008), in the first phase. vmax B is the
maximum growth rate (h−1) for the second phase.
Data Fitting and Statistical Analysis
The antimicrobial effectiveness amongst treatments was evalu-
ated with analysis of variance (one-way ANOVA) followed by
Bonferroni posttests for multiple comparisons using GraphPad
Prism™ 5 (GraphPad Software Inc., San Diego, CA, USA).
Plotting and data fitting were performed with GraphPad
Prism™ 5 (GraphPad Software Inc., San Diego, CA, USA).
The significance of the model parameters were assessed using
SigmaPlot version 11.0 from Systat Software, Inc. (San Jose,
CA, USA).
Results and Discussion
Pimaricin Stability in Different Matrices
Degradation kinetics were performed to calculate the half-life of
pimaricin in the two matrices assayed (YPD broth and grape
juice). The results of monitoring the pimaricin degradation are
illustrated in Fig. 3. Table 1 summarises the best-fit parameters
obtained for Eq. 2. At low temperatures (<37 °C), the pH effect
prevailed over the temperature effect. Despite performing the
grape juice assay at a temperature 12 °C lower than the YPD
broth assay, the rate of pimaricin degradation (k) in grape juice
was 2-fold higher (p=0.0091) than that observed in the culture
broth. This behaviour may be caused by the acidic conditions of
grape juice (pH 3.5), in which pimaricin may be rapidly degrad-
ed, producingmycosamine by hydrolysis of the glycosidic bond
Fig. 3 Variation of remaining pimaricin fraction (F), standardised
according to Eq. 1, in YPD broth at 37 °C (white-filled circles) and
grape juice at 25 °C (grey-filled circles) and 80 °C (black-filled circle).
The graph inset is an enlarged representation of the data in the 80 °C
series. The lines are the fitting curves generated from Eq. 2 (r2YPD broth
(37 °C)=0.9813; r
2
grape juice (25 °C)=0.9839; r
2
grape juice (80 °C)=0.9850)
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(Koontz et al. 2003). With respect to the Fmin value, there are no
significant differences (p=0.2393) between the culture broth
and grape juice. Despite the low temperature, in the long run
(t>250 h) pimaricin was completely degraded in both cases.
The calculated half-lives (Table 1) were 27 h in YPD broth,
and 13 h in grape juice. Pedersen (1992) has reported pimaricin
losses of 34 % at 50 °C during the preparation of YPD plates,
and the half-life of pimaricin in YPD plates stored at 6 °C under
dark conditions was 31 days. In our case (at lower tempera-
tures), regardless of whether the media was acidic or not, the
pimaricin half-life was notably lower, probably because our
assays were performed under light radiation where its chemical
stability has been reported to be low (Stark and Tan 2003;
Koontz et al. 2003). The same applies when comparing the
calculated half-lives in grape juice with those by Alberts et al.
(2011). These authors studied pimaricin degradation in wine
samples stored in standard wine bottles where artificial light
had no effect on the rate of degradation, probably due to the
absorption of the radiation by the glass. They reported half-lives
for the degradation of pimaricin in wine of approximately
20 days at 20 °C, 6 days at 30 °C and 2 days at 40 °C.
When the pimaricin-treated juice was heated up to
pasteurisation temperatures (80 °C) the pimaricin degradation
was significantly increased (Fig. 3). The k value was nearly 50-
fold higher (p=0.0021) at 80 °C than at 25 °C. Consequently,
the half-life was also reduced (0.27 h, Table 1). On the other
hand, there were no significant (p=0.1110) differences be-
tween the Fmin achieved in grape juice at 25 and 80 °C.
The results obtained show that pimaricin has a low stability
under normal conditions (heating, acidification, lighting) for
the production of fresh (non-sterilised) juices, which may po-
tentially reduce its antimicrobial activity. This suggests that
nanohydrogel-encapsulation may be a feasible procedure to
protect pimaricin from degradation, and thus, to improve its
antimicrobial activity.
Dose-Response Assessment of Pimaricin: IC50
Pimaricin is active in small quantities against almost all
moulds and yeasts that cause food spoilage. Most moulds
and yeast are sensitive to pimaricin concentrations lower than
10 and 3 ppm, respectively. The minimum inhibitorium con-
centration (MIC) for pimaricin varied from 0.5 to 2 ppm for
most species that can cause spoilage in beverages (Stark and
Tan 2003). Koontz and Marcy (2003) reported MIC values
against S. cerevisiae of 1.1±0.05 μg mL−1 in malt extract agar
plates. However, the half maximal inhibitory concentration
(IC50) for pimaricin in YPD broth and grape juice against a
food-spoilage microorganism has not been reported before.
We performed a dose-response analysis to evaluate the effect
of pimaricin on the growth of a food-spoilage indicator micro-
organism (S. cerevisiae).
The dose-response profiles obtained for each matrix are
represented in Fig. 4. The IC50 for pimaricin in culture broth
was 2.95± 0.06 μg mL−1 and in grape juice 1.74 ±
0.09 μg mL−1. It should be taken into account that even in
the absence of pimaricin, the latency of S. cerevisiae in grape
juice was 4.5 times higher than in culture broth. Grape juice is
poorer in nitrogen and proteins, so the yeast growth in this
mediummight be limited by the absence of essential nutrients.
This limitation should be strengthened in the presence of
pimaricin that acts binding to ergosterol in membrane cells,
Table 1 Pimaricin degradation parameters in different matrices and
temperatures calculated with Eq. 2
Matrices T (°C) Fmin k (h
−1) Half-life (h)
YPD
broth
37 0.057±0.009*** 0.025±0.002*** 27.29±1.697***
Grape
juice
25 0.044±0.006*** 0.053±0.003*** 13.05±0.807***
80 0.129±0.043n.s. 2.551±0.339** 0.272±0.036**
Values reported are the means±standard deviation (n=2)
n.s. not significant (p>0.05)
*p<0.05, significant; **p<0.01, very significant; ***p<0.001, extreme-
ly significant
Fig. 4 Dose-response curves: latency of Saccharomyces cerevisiae
cultures in YPD broth at 37 °C (a) and in grape juice at 25 °C (b),
obtained in response to the exposure to increasing concentrations of
pimaricin. The lines are the fitting curves generated from Eq. 3 (r2YPD
broth (37 °C)=0.9984; r
2
grape juice (25 °C)=0.9986).Dashed lines represent the
IC50 calculated with Eq. 3
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inhibiting relevant processes involved in cell regeneration (Te
Welscher et al. 2008). Therefore, the absence of precursors for
cellular regeneration can cause a further slowing down of the
growth. Maximum inhibitions (i.e. higher latencies) were also
higher in grape juice (217 h) than in YPD broth (129 h),
meaning the antimicrobial capacity of pimaricin is much
higher in grape juice than in culture broth.
Antimicrobial Activity of Pimaricin-Loaded PNIPA/AA
Nanohydrogels in a Food Model System
We next tested the antifungal activity in the food model sys-
temwhen pimaricin was loaded in PNIPA/AA nanohydrogels.
The experimental S. cerevisiae growth data (OD values) ob-
tained were fitted with the reparameterised logistic model
(Eq. 5) and reparameterised bilogistic model (Eq. 6) for series
without and with antifungal treatment, respectively.
The results, illustrated in Fig. 5 and summarised in Table 2,
show that pimaricin-loaded nanohydrogel was highly effec-
tive inhibiting the growth of the indicator strain. Treatments
with pimaricin (P, NPPNIPA(5) and NPPNIPA-20AA(5)) led to a 2-
fold reduction (p<0.05) in yeast growth compared to samples
without pimaricin. Pimaricin-free nanohydrogels (NPNIPA(5)
and NPNIPA-20AA(5)) seem to have no negative effect on yeast
growth as they showed no significant (p>0.05) differences
with control cultures (C) growth parameters, where no
nanohydrogels was applied.
In addition, the combination of antifungal and
nanohydrogel extended the latency of S. cerevisiae growth
further than pimaricin alone (Table 2). The λB was increased
significantly (p<0.05) from 12.39±0.54 to 81.19±0.17 h in P
and NPPNIPA-20AA(5) treatments, respectively.
Moreover, the advantage of using nanohydrogels with
acrylic acid can be noted when comparing both inhibition
curves. NPPNIPA-20AA(5) was able to stop S. cerevisiae growth
completely in 81.19±0.17 h, while NPPNIPA(5) only main-
tained the inhibition for 14.50±2.32 h, after which exponen-
tial growth was observed. In addition, there were no signifi-
cant (p>0.05) differences between the λB of samples treated
with P and NPPNIPA(5).
Ollé Resa et al. (2014) evaluated the antimicrobial activity
of pimaricin against S. cerevisiae employing a whey protein
concentrate solution as a model liquid food. They found that
20 ppm of pimaricin reduced S. cerevisiae counts to 1.25
log CFU mL−1 after 96 h and maintained the antifungal effect
during four additional days at 25 °C. The lower temperature
assayed (25 vs. 37 °C) explains that the inhibition time (λB)
was higher than that obtained with free pimaricin treatment
(P). However, similar inhibition time (λB) was obtained when
pimaricin was released from PNIPA nanohydrogels
copolymerized with AA (NPPNIPA-20AA(5)), despite being per-
formed at a higher temperature that could increase pimaricin
degradation and accelerate microbial growth.
These results are consistent with previous pimaricin release
studies carried out in water Fuciños et al. (2014b), showing
Fig. 5 Effect of different antimicrobial devices on Saccharomyces
cerevisiae growth in a food model system (YPD broth). Treatments
without pimaricin: NPNIPA(5) (black-filled square), NPNIPA-20AA(5)
(white-filled square) and C (grey-filled square). Treatments with
pimaricin: NPPNIPA(5) (black-filled circle), NPPNIPA-20AA(5) (white-filled
circle) and P (grey-filled circle). The line is the fitting curve generated
from Eqs. 5 and 6
Table 2 Growth parameters of Saccharomyces cerevisiae in culture broth under different antimicrobial treatments, calculated with Eqs. 5 and 6
Treatment A vmax A (h
−1) A0 B vmax B (h
−1) λB (h) r
2
C – – – 0.433±0.009*** 0.069±0.008*** 1.554±0.475** 0.9731
NPNIPA(5) – – – 0.458±0.015*** 0.105±0.025** 1.231±0.607
n.s. 0.9631
NPNIPA-20AA(5) – – – 0.393±0.008*** 0.059±0.007*** 1.313±0.288* 0.9865
P 0.049±0.004*** 0.015±0.009n.s. 0.019±0.007* 0.219±0.004*** 0.033±0.004*** 12.390±0.541*** 0.9946
NPPNIPA(5) 0.088±0.008*** 0.014±0.005* 0.023±0.009* 0.292±0.009*** 0.011±0.002*** 14.500±2.230*** 0.9856
NPPNIPA-20AA(5) 0.052±0.002*** 0.035±0.022
n.s. 0.020±0.008* 0.243±0.008*** 0.117±0.272n.s. 81.191±0.167*** 0.9860
Values reported are the means±standard deviation (n=2)
n.s. not significant (p>0.05)
*p<0.05, significant, **p<0.01, very significant, ***p<0.001, extremely significant
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PNIPA nanohydrogels copolymerized with AA allowing for a
slower but sustained release of pimaricin. This system allows
for maintaining high pimaricin levels able to control yeast
growth.
Antimicrobial Activity of Pimaricin-Loaded PNIPA/AA
Nanohydrogels in a Real Food: Grape Juice
In view of the good results in liquid food model system
(Sect. 3.3), in the study of antimicrobial activity of
pimaricin-loaded PNIPA/AA nanohydrogels was evaluated
with PNIPA-20AA(5) nanohydrogels as an alternative to tra-
ditional treatments, which consists of free pimaricin directly
added to food bulk.
Figure 6 compares of the effect on yeast growth of
pimaricin treatments directly added to a grape juice or includ-
ed in the nanohydrogel. Treatments without pimaricin (C and
NPNIPA-20AA(5)) seem to have no effect on S. cerevisiae growth
in contrast to pimaricin treatments (P and NPPNIPA-20AA(5)).
Table 3 shows the growth parameters of S. cerevisiae in the
presence of different treatments, after fitting the experimental
growth data to Eq. 5.
There were no significant (p>0.05) differences between
S. cerevisiae growth parameters (Table 3) of treatments with-
out pimaricin (C and NPNIPA-20AA(5)). The pimaricin treat-
ments (P and NPPNIPA-20AA(5)) completely inhibit the growth
of S. cerevisiae (Fig. 6). These results confirm those obtained
in the liquid food model system (Sect. 3.3) where the
nanohydrogel did not interfere with S. cerevisiae growth.
Fuciños et al. (2014b) proposed an equation to calculate the
pimaricin released from nanohydrogels at different pH and
temperature conditions. So, the maximum concentration of
pimaricin released during the entire experiment, under the
grape juice storage conditions used (see Sect. 2.4.4), would
be equal to 0.90±0.0002 μg mL−1. This concentration is sig-
nificantly lower (p<0.05) than the IC50 calculated in Sect. 3.2
for free pimaricin in grape juice (1.74±0.09 μg mL−1). There-
fore, the nanohydrogel acts protecting pimaricin from degra-
dation providing a more effective inhibition. So specific inhi-
bition was calculated by applying Eq. 4.
The inset in Fig. 6 represents the specific inhibition of
S. cerevisiae with P and NP treatments, showing that the spe-
cific inhibition with the NPPNIPA-20AA(5) treatment is clearly
higher than that of the P treatment.
Conclusions
This work demonstrates the usefulness of pimaricin-loaded
nanohydrogel devices to control the microbial spoilage of
grape juice, providing an effective inhibition of yeast growth
due to the combination of two mechanisms: slow and con-
trolled release of pimaricin and protection against environ-
mental degradation of the antifungal compound. These release
devices also reduced the pimaricin concentration in the juice
but while still obtaining a yeast inhibitory effect.
These results demonstrate the possibility of using
pimaricin-loaded nanohydrogels in active packaging by their
incorporation in food contact materials in order to extend the
shelf life of refrigerated and pasteurised foods once the pack-
aging has been opened.
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Fig. 6 Effect of different antimicrobial devices on Saccharomyces
cerevisiae growth in grape juice. Control samples without pimaricin:
NPNIPA-20AA(5) (white-filled square) and C (grey-filled square). Samples
with pimaricin: NPPNIPA-20AA(5) (white-filled circle) and P (grey-filled
circle). The line is the fitting curve generated from Eq. 5. The dashed
line shows the temperature cycling of the release media between 37 and
15 °C. The figure inset represents the specific inhibition at different times
Table 3 Growth parameters of Saccharomyces cerevisiae in grape juice under different antimicrobial treatments, calculated with Eq. 5
Treatment B vmax B (h
−1) λB (h) r
2
C 0.447±0.011*** 0.030±0.002*** 15.440±0.628*** 0.9886
NPNIPA-20AA(5) 0.460±0.032*** 0.021±0.003*** 15.381±1.770*** 0.9415
P – – – –
NPPNIPA-20AA(5) – – – –
Values reported are the means±standard deviation (n=2)
***p<0.001, extremely significant
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